Cureatr Welcomes Rose Abraham, PharmD, as Director of Clinical Pharmacy Operations

NEW YORK–(COMMERCIAL THREAD) –Curator, Inc., a comprehensive drug management (CMM) technology and services company, announces that Rose Abraham, PharmD, has joined the company as director of clinical pharmacy operations.

Since Cureatr’s change of focus from secure messaging and clinical transition notifications to full medication management in 2019, the company has deployed software and services to address the suboptimal medication management issue of $ 528 billion. of dollars in the United States.1. To fulfill this mission, Cureatr relies on Medicines 360 °. This real-time visualization of accurate drug data not only captures what’s in a patient’s electronic medical record, but also what the patient has actually paid for through Pharmacy Benefits Manager (PBM) claims and claims. Nationwide real-time pharmaceutical cash transactions.

Curator also offers clinical interventions by clinical telepharmacists certified by the Board of Directors with accredited residency training. Powered by Meds 360 °, this comprehensive clinical medication management service functions as an extension of a healthcare team, with Cureatr pharmacists virtually assessing patients, evaluating medication care plans and enabling real-time monitoring of patient behavior. taking medication. This allows health care providers to respond quickly when new drugs may prove to be unsafe or when non-adherence to drugs may harm patients. The addition of Dr. Abraham provides Cureatr with valuable expertise and leadership as the company expands its clinical telepharmacy services.

In her role as Director of Clinical Pharmacy Operations, Dr. Abraham will oversee all of Cureatr’s pharmacy operations, including planning, recruiting, organizing, supervising and quality assurance activities. Dr Abraham will also play a crucial role in the development of Cureatr’s clinical pharmacy strategy and in supporting business development.

“I was drawn to Cureatr because of its ability to have a profound impact on patient lives and clinical outcomes,” said Dr Abraham. “With Cureatr, pharmacists can exercise their license to the fullest and keep patients out of the hospital.”

“We are delighted that Dr Abraham is joining the Cureatr team,” said Michael Ross, MD, MHA, Medical Director of Cureatr. “To take our telepharmacy services to the next level, we recognized the need to bring in an expert clinical pharmacist with strong leadership experience. With Dr. Abraham, we have filled this need.

Dr Abraham has over a decade of pharmacy experience, working as a clinical pharmacist in Maryland and New York, where she focused on specialty pharmacy and care management through drug therapy management ( MTM). More recently, Dr Abraham has worked for Capsule, a healthcare technology company that is rebuilding pharmacy from the inside out. She obtained her doctorate in pharmacy from Massachusetts College of Pharmacy and Health Sciences and is currently a candidate for the Executive MBA at Quantic School of Business and Technology, with a graduation year scheduled for 2021.

To learn more about Dr Abraham on his new role, the growing value of telepharmacy, and Cureatr’s role in suboptimal medication management, read this maintenance.

About Cureatr, Inc.

Cureatr is a comprehensive medication management (CMM) company dedicated to fixing the $ 528 billion suboptimal medication management problem in the United States. Using our technology, we ensure that prescribers have up-to-date and accurate medication lists in real time when they write new prescriptions and perform medication reconciliations; easily drawing their attention to potential drug therapy problems, such as drug duplication, non-adherence and drug addiction; and by generating real-time notifications for caregivers when patients are taking potentially dangerous new drugs or not taking their maintenance drugs. We also offer clinical services that put our technology in the hands of our own board-approved clinical pharmacists, enabling them to ensure ongoing coordination of care for their complex drug therapies, as our vision is a world where people who need drugs can access and use them safely. , and effectively so that they can live long and healthy lives, in the real world rather than in the hospital. Visit www.cureatr.com to learn more.

1 – IMS Health, New England Healthcare Institute, Express Scripts, American Heart Assn, Premara Blue Cross, National Institutes of Health Watanabe JH, Mcinnis T, Hirsch JD. Cost of prescription drug morbidity and mortality. Ann Pharmacother, 2018.

The references: IMS Health, New England Healthcare Institute, Express Scripts, American Heart Assn, Premara Blue Cross, National Institutes of Health

Watanabe JH, Mcinnis T, Hirsch JD. Cost of prescription drug morbidity and mortality. Ann Pharmacother, 2018.


Source link

Comments are closed.